Antimutagenic activities of two suspected anticarcinogenic bifunctional organoiron seleno-terephthalate derivatives

References

• Abdullaev, G. B., Gasanov, G. G., Ragimov, R. N., Teplyakov, G. V., Mekhtiev, M. A., Jafarov, H. I. (1973). Selenium and tumor growth in experiments. Dokl Akad Az SSR 29:18–24.
   Google Scholar
• Arenholt-Bendsleve, D., Abdulla, M., Jepsrn, A., Pedeson, E. (1988). Effect of organic and inorganic selenium on human keratinocytes. Trace Elem Med 5:29–34.
   Web of Science ®Google Scholar
• Belicova, A., Krizkova, L., Dobias, J., Krajcovic, J., Ebringer, L. (2004). Synergic activity of selenium and probiotic bacterium Enterococcus faecium M-74 against selected mutagens in Salmonella assay. Microbiol (Praha) 49:301–305.
   PubMed Web of Science ®Google Scholar
• Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G. O., et al. (1993). Nutrition intervention trials in Laxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in general population. J Natl Cancer Inst 85:1483–1491.
   PubMed Web of Science ®Google Scholar
• Bronzetti, G., Cini, M., Caltavuturo, L., Fiorio, R., Croce, C. D. (2003). Antimutagenicity of sodium selenite in Chinese hamster V79 cells exposed to azoxymethane, methylmethansulphonate, and hydrogen peroxide. Mutat Res 523–524:21–31.
   Google Scholar
• Cantor, A., Scot, M., Noguch, T. (1976). Biological availability of selenium in feedstuffs and selenium compounds for prevention of exudative diathesis in chicks. J Nutr 105:96–105.
   Web of Science ®Google Scholar
• Clark, L. C. (1985). The epidemiology of selenium and cancer. Fed Proc 44:2584–2589.
   PubMedGoogle Scholar
• De Flora, S. (1988). Problems and aspects of antimutagenesis and anticarcinogenesis. Mutat Res 202:279–283.
   PubMed Web of Science ®Google Scholar
• Ferguson, L. R. (1994). Antimutagens: a cancer chemopreventive agents in the diet. Mutat Res 307:395–410.
   PubMed Web of Science ®Google Scholar
• Fiala, E. S., Staretz, M. E, Pandya, G. A, El-Bayoumy, K., Hamilton, S. R. (1998). Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis (Oxford) 19:597–604.
   PubMed Web of Science ®Google Scholar
• Gichner, T., Vousinas, G., Patrineli, A., Kappas, A., Plewa, M. (1994). Antimutagenicity of three isomers of aminobenzoic acid in Salmonella typhimurium. Mutat Res 309:201–210.
   PubMed Web of Science ®Google Scholar
• Greeder, G. A., Milner, J. A. (1980). Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells. Science 209:825–827.
   PubMed Web of Science ®Google Scholar
• Hu, Q., Xu, J., Chen, L. (2005). Antimutagenicity of selenium-enriched rice on mice exposure to cyclophosphamide and mitomycin C. Cancer Lett 220:29–35.
   PubMed Web of Science ®Google Scholar
• Insel, W. (1996). Perspectives in nutrition (pp 396-570). New York: Mosby.
   Google Scholar
• Ip, C., Ganther, H. E. (1992). Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13:1167–1170.
   PubMed Web of Science ®Google Scholar
• Shamberger, R. J., Tytco, S. A., and Willis, C. E. (1976). Antioxidants and cancer, selenium, and age- adjusted human cancer mortality. Arch Environ Health 31:231–235.
   PubMedGoogle Scholar
• Jacob, J. H., Khalil, A. M., Maslat, A. O. (2004). In vitro cytogenetic testing of an organoselenium compound and its sulfur analogue in cultured rat bone marrow cells. J Carcinog 3:5.
   PubMedGoogle Scholar
• Jibril, I., Abd Alhadi, E., Hamadah, Z. (2000). Imide and anhydride bridged organoiron dinuclear homo and hetero dichalcogen carboxylate complexes [CPFe(CO)2 ECO(C6H4)CO]2 NH and [CPFe(CO)2 ECO(C6H4)CO]2 O [E = S, Se]. Trans Met.Chem 25:407–410.
   Google Scholar
• Khalil, A. M. (1989). The induction of chromosome aberrations in human purified peripheral blood lymphocytes following in vitro exposure to selenium. Mutat Res 224:503–506.
   PubMed Web of Science ®Google Scholar
• Khalil, A. M., Maslat, A. O. (1990). Chromosome aberrations, sister-chromatid exchanges, and cell-cycle kinetics in human peripheral blood lymphocytes exposed to organoselenium in vitro. Mutat Res 232:227–232.
   PubMed Web of Science ®Google Scholar
• Khalil, A. M. (1994). Genotoxicity of two pharmacologically important selenium compounds (selenocystine and selenopuridine) in cultured in human blood lymphocytes. Toxicol Env Chem 41:147–154.
   Web of Science ®Google Scholar
• Kuroda, Y., Inoue, T. (1988). Antimutagenesis by factors affecting DNA repair in bacteria. Mutat Res 202:387–391.
   PubMed Web of Science ®Google Scholar
• Kuroda, Y., Jain, A., Tezuka, H., Kada T. (1992). Antimutagenicity in cultured mammalian cells. Mutat Res 267:201–209.
   PubMed Web of Science ®Google Scholar
• Maron, D., Ames, B. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215.
   PubMed Web of Science ®Google Scholar
• Maslat, A. O., Jibril, I., Abussaud, M., Abd Alhadi, E., Hamada, Z. (2002). Synthesis and biological study of new series of bifunctional organothio- and seleno-terephthalte derivatives. Appl Organomet Chem 16:44–50.
   Web of Science ®Google Scholar
• Maslat, A. O., Khalil, A. M. (1991). Mutagenic effects of two anticarcinogenic suspected organoselenium compounds in Salmonella typhimurium. Toxicol Env Chem 33:23–29.
   Web of Science ®Google Scholar
• Morison, R. T., Boyd, R. L. (1983). Organic chemistry, 4th ed. (p 638). Boston, London, Sydney: Allyn and Bacon.
   Google Scholar
• Phillips, P., Baetz, A. (1981). Diet and resistance to disease (p 44). New York, London: Plennum Press.
   Google Scholar
• Poirier, K. A., Milner, J. A. (1979). The effect of various selenocompounds on Ehrlich ascites tumor cells. Biol Trace Elem Res 1:25–34.
   PubMedGoogle Scholar
• Poirier, K. A., Milner, J. A. (1983). Factors affecting the antitumorigenic properties of selenium in mice. J Nutr 113:2147–2154.
   PubMed Web of Science ®Google Scholar
• Romert, L., Jansson, T., Curvall, M., Jenssen, D. (1994). Screening for agents inhibiting the mutagenicity of extracts and constituents of tobacco products. Mutatat Res 322:97–110.
   PubMed Web of Science ®Google Scholar
• Saito, Y., Fiji, T., Honda, M., Maeda, A., Seo, H., Chikuma, M. (2000). Comparison of cytotoxic properties of selenium compounds on Ehrlich ascites tumor cells and rat red cells. In the proceedings of the seventh international symposium: selenium in biology and medicine, October 1–5, Venenzia.
   Google Scholar
• Schrauzer, G. N., McGinness, J. E., Schnider, C. J. (1978). Selenium and cancer: effects of selenium and of the diet on the genesis of spontaneous mammary tumors in virgin inbred female C3H/St mice. Bioinorg Chem 8:387–396.
   PubMedGoogle Scholar
• Siegel, B. Z., Siegel, S. M., Correa, T., Dagan, C., Galvez, G., Leeloy, L., et al. (1991). The protection of invertebrates, fish, and vascular plants against inorganic mercury poisoning by sulfur and selenium derivatives. Arch Environ Contam Toxicol 20:241–246.
   PubMed Web of Science ®Google Scholar
• Sprinker, L., Harr, J. H., Newborn, P., Weswig, P. (1971). Selenium deficiency lesions and vitamin E supplemented rations. Nutr Rep Intl 4:335–370.
   Google Scholar
• Vadagama, J. V., Wu, Y., Shen, D. S., Hisa, J. B. (2000). Effect of selenium in combination with adriamycin or taxol on several cancer cells. Anticancer Res 20:1391–1414.
   PubMed Web of Science ®Google Scholar